However, in this study, an inverse correlation between serum IgG3 levels and time until MS conversion was observed, suggesting the potential of serum IgG3 to complement the categorical risk assessment from using MRI data, and incorporate the dimension of time in the prognostic assessment when an individual presents with CIS. The gene discussed is IGHG3; the disease is in situ carcinoma.